China's most promising SME list

Summary: The list of listed companies in the listing part of the list we found that compared to the last, listed overseas companies more than 8, reached 14. This is partly because of the freeze on the Chinese IPO market and, on the other hand, the fact that overseas markets, especially U.S.

Regional distribution of listed companies

In the list of listed parts we found that compared to the last, listed overseas companies more than 8, reached 14. This is partly because of the freeze on China's IPO market and, on the other hand, the renewed launch of IPOs by Chinese companies overseas, especially in the US capital markets. A total of 28 companies have been on the list again this year after last year's list, and 25 of them are listed on the gem, which can be seen in comparison with the strength of China's economic restructuring and the outstanding performance of the gem last year.

In this year's list, the internet and mobile Internet, software technology, clean technology, health care, electronic information, consumer, entertainment media and other industries leading the trend, while the proportion of traditional manufacturing industry continues to decline. Overall, Beijing's dominance in these areas continues to widen. In the unlisted part of the list, although the total number of companies headquartered in Beijing, Shanghai and Guangdong is almost the same as in the previous year, more than 70%, the number of companies in Beijing alone has risen from 37 last year to 47 now, close to half of the list.

Comparison of financial data of listed companies

By listing two unlisted listings, we can see that they have advantages in different areas: in sales revenue, net profit and total assets of three items, listed companies are much larger than the list of unlisted enterprises, the former 2012 years of average sales revenue, average net profit and average total assets reached 552 million respectively , 140 million and 1.337 billion, while the three values of unlisted companies were only 171 million, 28 million and 165 million in the same period, but in the development potential, the performance of unlisted enterprises is better than listed enterprises. Listed companies in the last three years of sales growth in the median and net profit growth in the median rate of 37% and 35%, the seemingly good results in unlisted companies 66% and 158% in front of the figure is only slightly inferior.

The internet has become a strong driver of the growth of a moving enterprise, and the mobile Internet is undoubtedly the fastest-growing area, as seen from the top two lists. Boya is ranked first in the listing list, and its mobile chess game is not only widely praised in mainland China, but also in the leading position in the relevant fields such as Hong Kong, Macao and other places. The Kai-UK network, which topped the list of unlisted listings, turned out to be a community game and is now starting to enter the field of mobile game development. After this change, its revenue situation has also gained the new big development. The Ministry of Industry recently issued 4G licences to the three major telecom operators in China, which means that there will be new opportunities in many fields including mobile Internet, electronic commerce and information dissemination.

Through this list we can see that professional services combined with Internet technology is a prominent feature of the listed companies, many companies are through for their customers in the circulation, security, information and other fields to provide professional services, so as to obtain their own rapid growth and achieve a successful transformation. For example, the unlisted list of Ruijin ("Ruijin: the catalytic converter of the electric merchant ecosystem), which is based on the data and the support of the software and hardware technology, has started to provide the integrated marketing and product supply chain management Service to the traditional industry from the simple electric dealers. Thus become the Internet integration solution provider.

With the urbanization, aging population, the pharmaceutical health and consumption areas of entrepreneurial and growth opportunities continue to be strong. The strength of China's research and development is increasingly evident in the Forbes list of potential companies. For example, the Zhejiang Beier pharmaceutical company, founded by a number of overseas medical doctors, has developed a drug that can treat lung cancer, which has been recognized internationally. Reports on the company can be read on the cover of Forbes magazine's Chinese version.

In the process of making the list, we follow the Forbes Chinese version of the potential business evaluation of the consistent standard: 2012 sales in the 10 million to 1 billion yuan, the main business in mainland China's small and medium-sized enterprises. According to the growth index (growth rate and net profit growth rate) of the enterprise in the past three years (2010 to 2012), profitability indicators (sales margin), return indicators (total asset return and return on equity) and scale indicators (total sales and net profit) are ranked, based on a large number of corporate data, We also visited some of the best candidates, and eventually selected 100 companies listed and unlisted.